TECHNOLOGY LICENSING OPPORTUNITY: Thermostable GlowTag (YFAST)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
TRIAD - DOE CONTRACTOR
Contract Value
Not provided
Codes & Classification
Solicitation Number
-
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
6505
Additional Details
Documents1
The Los Alamos National Laboratory (LANL), operating under the TRIAD DOE Contractor, has issued a special notice regarding a technology licensing opportunity for the Thermostable GlowTag (YFAST), an innovative platform designed to advance enzyme engineering for high-temperature industrial applications. This opportunity is not a solicitation for external development services, but rather an invitation for companies to license and commercialize a patented (and patent-pending) technology developed by LANL scientists.
Purpose and Scope:
The Thermostable GlowTag (YFAST) technology addresses a critical challenge in the enzyme engineering industry: the need for enzymes that can reliably function at elevated temperatures, which are prevalent in sectors such as biofuel production, waste management, chemical manufacturing, and more. Traditional enzymes, typically sourced from mesophilic organisms, tend to degrade under heat, while naturally thermostable enzymes are rare and difficult to manipulate. Existing screening methods for thermostable enzymes are slow and prone to inaccuracies, impeding efficient development.
Intended Outcomes:
LANL’s innovation introduces a high-throughput screening platform that leverages a thermophilic microorganism, Parageobacillus thermoglucosidasius, and a specially engineered thermostable fluorogenic reporter protein (tsFAST). This system enables scalable, rapid selection of enzyme variants that remain stable and functional at high temperatures. The technology allows for the re-engineering of common mesophilic enzymes for heat resistance, streamlines the screening process through direct fluorescence-based selection, and reduces operational costs by producing enzymes that do not require refrigeration.
Key Requirements and Deliverables:
- The licensing opportunity is for the use and commercialization of the tsFAST technology, which includes:
- A thermostable fluorogenic reporter that emits an optical signal correlating to the quantity and proper folding of the fused protein.
- A platform for rapid, high-throughput screening of enzyme stability and activity at elevated temperatures.
- Methods for engineering mesophilic enzymes to function in high-heat environments.
- Capabilities for screening and optimizing proteins from thermophilic sources.
- The technology is currently at Technology Readiness Level (TRL) 2-3, indicating early-stage development with proof-of-concept established.
- U.S. non-provisional patent pending (19/284504) and reference LA-UR-25-32018.
Market Applications:
Potential applications span a wide range of industries, including:
- Biofuels
- Waste Management
- Chemical and Pharmaceutical Manufacturing
- Food and Beverage Processing
- Textiles and Detergents
Contracting Entity and Location:
- Contracting Entity: TRIAD - DOE CONTRACTOR (Federal Office)
- Place of Performance: Los Alamos, New Mexico, United States
Classification and Codes:
- NAICS Code: 541714 (Research and Development in Biotechnology, except Nanobiotechnology)
- Product Service Code: 6505
Procurement Type and Set-Aside:
- Notice Type: Special Notice (Licensing Opportunity)
- Set-Aside Type: None (open to all interested parties)
Contact Information:
- Primary Contact: Caleb Ledgerwood ([email protected])
- Secondary Contact: Lindsay Augustyn ([email protected])
- Additional information and technology search resources are available at:
- https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology
- https://www.lanl.gov/engage/collaboration/feynman-center/tech-and-capability-search
Special Considerations:
- This notice is for licensing the technology, not for external R&D or service contracts.
- Both exclusive and non-exclusive licensing agreements are available to existing and start-up companies.
- The technology is protected by patent and copyright, and licensing is managed through LANL’s Tech Partnerships program.
Summary for Contractors:
This opportunity is ideal for organizations seeking to enhance their product offerings with robust, thermostable enzymes, particularly those operating in high-temperature industrial environments. The technology offers a unique, scalable solution to a longstanding bottleneck in enzyme development, with broad applicability across multiple sectors. Interested parties should evaluate their capacity for commercialization and integration of early-stage biotechnologies and contact LANL’s licensing office for further discussion and due diligence.
For full details and to access the official notice, visit: https://sam.gov/opp/ab9e2c311b9f4ecba1ffa5621975d81e/view